- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
[email protected]
Attachments1:55 AM (18 hours ago)
to nataphcv, undefined, natap
www.natap.org
A Single Dose of RG-101, a GalNAc-Conjugated Oligonucleotide Targeting miR-122, Results in Undetectable HCV RNA Levels in Chronic Hepatitis C Patients at Week 28 of Follow-up
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
M.H. van der Ree 1, J.M.L. de Vree 2, F. Stelma 1, S.B. Willemse 1, M. van der Valk 1, S. Rietdijk 1,3, R. Molenkamp 4, J. Schinkel 4, S. Hadi 5, M. Harbers 5, A. van Vliet 5, J. Udo de Haes 5, P. Grint 6, S. Neben 6, N. Gibson 6 and H.W. Reesink 1
Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
Dep. of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands
Dep. of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
Dep. of Medical Microbiology, Clinical Virology Laboratory, Academic Medical Center, Amsterdam, The Netherlands
PRA Healthsciences, Zuidlaren, The Netherlands
Regulus Therapeutics, San Diego, CA, USA
www.natap.org
RG-101单剂量,一个半乳糖胺,共轭寡核苷酸靶向后续的miR-122,结果在检测不到HCV RNA水平在慢性丙型肝炎患者在第28周
儒勒·莱文报道
AASLD 2015年十一月13日至17号旧金山
M.H。范德Ree的1,J.M.L.德Vree 2,F Stelma 1,S·B· WILLEMSE 1,M.范德瓦尔克1,S Rietdijk 1,3,R Molenkamp研究4,J.辛克尔4,S.哈迪5,M Harbers 5,A。凡弗利特5,J.乌德黑斯5, P.格林特6,S Neben 6,N吉布森6和硬件Reesink 1
DEP的保护。胃肠病学和肝病学术医疗中心,阿姆斯特丹,荷兰
DEP的保护。胃肠病学和肝病,格罗宁根大学医学中心,格罗宁根,荷兰
DEP的保护。胃肠病学和肝病的Onze Lieve Vrouwe Gasthuis,阿姆斯特丹,荷兰
DEP的保护。医学微生物学,临床病毒学实验室,学术医学中心,阿姆斯特丹,荷兰
PRA美国健康,泽伊德拉伦,荷兰
轩辕治疗,圣地亚哥,CA,美国
Go
|
|